168 related articles for article (PubMed ID: 28407688)
21. Se-Allylselenocysteine induces autophagy by modulating the AMPK/mTOR signaling pathway and epigenetic regulation of PCDH17 in human colorectal adenocarcinoma cells.
Wu JC; Wang FZ; Tsai ML; Lo CY; Badmaev V; Ho CT; Wang YJ; Pan MH
Mol Nutr Food Res; 2015 Dec; 59(12):2511-22. PubMed ID: 26395119
[TBL] [Abstract][Full Text] [Related]
22. Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer.
Wei JL; Fang M; Fu ZX; Zhang SR; Guo JB; Wang R; Lv ZB; Xiong YF
Oncotarget; 2017 Jul; 8(30):49318-49328. PubMed ID: 28525387
[TBL] [Abstract][Full Text] [Related]
23. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
[TBL] [Abstract][Full Text] [Related]
24. Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
Han YT; Chen XH; Gao H; Ye JL; Wang CB
Acta Pharmacol Sin; 2016 Feb; 37(2):264-75. PubMed ID: 26707141
[TBL] [Abstract][Full Text] [Related]
25. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
26. Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
Abu El Maaty MA; Strassburger W; Qaiser T; Dabiri Y; Wölfl S
Mol Carcinog; 2017 Nov; 56(11):2486-2498. PubMed ID: 28618116
[TBL] [Abstract][Full Text] [Related]
27. Pre-clinical characterization of PKC412, a multi-kinase inhibitor, against colorectal cancer cells.
Li JP; Huang ZJ; Lu XS; Zhou YC; Shao Y; He XP; Chen SR; Wang DD; Qin LS; Sun WH
Oncotarget; 2016 Nov; 7(47):77815-77824. PubMed ID: 27780925
[TBL] [Abstract][Full Text] [Related]
28. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
29. AZD-4547 exerts potent cytostatic and cytotoxic activities against fibroblast growth factor receptor (FGFR)-expressing colorectal cancer cells.
Yao TJ; Zhu JH; Peng DF; Cui Z; Zhang C; Lu PH
Tumour Biol; 2015 Jul; 36(7):5641-8. PubMed ID: 25691251
[TBL] [Abstract][Full Text] [Related]
30. The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.
Lei S; Ding Y; Fu Y; Wu S; Xie X; Wang C; Liang H
PLoS One; 2017; 12(10):e0184501. PubMed ID: 29065135
[TBL] [Abstract][Full Text] [Related]
31. CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
Xie Z; Wang J; Liu M; Chen D; Qiu C; Sun K
PLoS One; 2017; 12(3):e0173252. PubMed ID: 28334043
[TBL] [Abstract][Full Text] [Related]
32. mTOR inhibition sensitizes ONC201-induced anti-colorectal cancer cell activity.
Jin ZZ; Wang W; Fang DL; Jin YJ
Biochem Biophys Res Commun; 2016 Sep; 478(4):1515-20. PubMed ID: 27565731
[TBL] [Abstract][Full Text] [Related]
33. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.
Chen MB; Yang L; Lu PH; Fu XL; Zhang Y; Zhu YQ; Tian Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):954-60. PubMed ID: 26071354
[TBL] [Abstract][Full Text] [Related]
35. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
[TBL] [Abstract][Full Text] [Related]
36. PF-06409577 activates AMPK signaling to protect retinal pigment epithelium cells from UV radiation.
Li XF; Liu XM; Huang DR; Cao HJ; Wang JY
Biochem Biophys Res Commun; 2018 Jun; 501(1):293-299. PubMed ID: 29733844
[TBL] [Abstract][Full Text] [Related]
37. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.
Mogavero A; Maiorana MV; Zanutto S; Varinelli L; Bozzi F; Belfiore A; Volpi CC; Gloghini A; Pierotti MA; Gariboldi M
Sci Rep; 2017 Nov; 7(1):15992. PubMed ID: 29167573
[TBL] [Abstract][Full Text] [Related]
38. GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings.
Jiang H; Liu W; Zhan SK; Pan YX; Bian LG; Sun B; Sun QF; Pan SJ
PLoS One; 2016; 11(8):e0161017. PubMed ID: 27532105
[TBL] [Abstract][Full Text] [Related]
39. Cryptotanshinone induces G1 cell cycle arrest and autophagic cell death by activating the AMP-activated protein kinase signal pathway in HepG2 hepatoma.
Park IJ; Yang WK; Nam SH; Hong J; Yang KR; Kim J; Kim SS; Choe W; Kang I; Ha J
Apoptosis; 2014 Apr; 19(4):615-28. PubMed ID: 24173372
[TBL] [Abstract][Full Text] [Related]
40. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
